EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Tailored Amino Acid Treatment for Pediatric Patients With Mitochondrial Aminoacyl‐ tRNA Synthetase Deficiencies

I J J Muffels iD, G Kok, Z Tang, L S Medeiros iD, F O Poswar iD, W P Vermeij iD, R Rodenburg iD, K Smit iD, S K Sukumaran iD, S B Wortmann iD, L Averdunk iD, J Munch und 10 weitere

Journal of Inherited Metabolic Disease · 2026

DOI: 10.1002/jimd.70254 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Inherited Metabolic Disease, 2026. Verfasst von I J J Muffels und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Metabolic Diseases, Division Pediatrics, Wilhelmina Children's Hospital University Medical Centre Utrecht, Utrecht University, Utrecht,…. Hauptthemen laut MEDLINE: Amino Acyl-tRNA Synthetases, Amino Acids, Mitochondria, Mitochondrial Diseases. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Tjallingh Roorda.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aminoacyl‐tRNA synthetases (ARSs) facilitate the loading of transfer RNAs with their cognate amino acids in the cytosol (ARS1), mitochondria (ARS2), or both (dual ARS). ARS deficiencies are clinically heterogeneous and can cause severe, occasionally fatal disease. Supplementation with cognate amino acids to prevent local amino acid depletion has shown promise in ARS1 deficiencies, but its potential in ARS2 deficiencies remains largely unexplored. We investigated the effects of cognate amino acid depletion on mitochondrial function in fibroblasts from seven patients with ARS2 deficiencies using Seahorse respirometry and imaging flow cytometry. During amino acid depletion, patient fibroblasts showed decreased mitochondrial membrane potential and reduced basal and maximal respiratory capacity. We additionally evaluated oral cognate amino acid supplementation in nine patients with SARS2, EARS2, LARS2, WARS2, FARS2, or VARS2 deficiencies. Supplementation was well tolerated, with no adverse effects observed. Several patients showed clinical improvements during treatment, including improved development, increased growth, and/or improved cardiac function. In two patients, treatment discontinuation coincided with severe neurological regression. Together, these findings demonstrate that assessing mitochondrial function during cognate amino acid depletion provides a novel functional assay for ARS2 deficiencies that may aid variant interpretation and supports a biological rationale for cognate amino acid supplementation. Clinical supplementation was well tolerated and showed preliminary beneficial effects. These findings support further investigation of cognate amino acid supplementation as a potential supportive treatment strategy for patients with ARS2 deficiencies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amino Acyl-tRNA SynthetasesAmino AcidsMitochondriaMitochondrial DiseasesHumansMaleFemaleChild, PreschoolFibroblastsInfantChildMembrane Potential, MitochondrialDietary Supplements

Stichwörter der Autor:innen

amino acid supplementationaminoacyl‐tRNA synthetase deficiencygenetic diseasemetabolic disordermitochondrial diseaseseahorse

Substanzen

Amino Acyl-tRNA SynthetasesAmino Acids

Autor:innen und Institutionen

  • Department of Metabolic Diseases, Division Pediatrics, Wilhelmina Children's Hospital University Medical Centre Utrecht, Utrecht University, Utrecht, the Netherlands.
  • Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
  • Oncode Institute, Utrecht, the Netherlands.
  • Postgraduate Program in Genetics and Molecular Biology, Federal University of Rio Grande do Sul, Porto Alegre, Brazil.
  • Radboud Center for Mitochondrial Medicine, Department of Human Genetics, Radboud UMC, Nijmegen, the Netherlands.
  • Department of Cardiology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.

ORCID-Profile: I J J Muffels, L S Medeiros, F O Poswar, W P Vermeij, R Rodenburg, K Smit, S K Sukumaran, S B Wortmann, L Averdunk, J Pak-Lam Ho, A M K Kwok, E E S Nieuwenhuis, P M van Hasselt, I V D Schwartz, C M A Lubout, A M Bosch, K Koop, E M M Hoytema van Konijnenburg, S A Fuchs

Förderung

  • Tjallingh Roorda

Zitieren

APA

Muffels, I. J. J., Kok, G., Tang, Z., Medeiros, L. S., Poswar, F. O., Vermeij, W. P., Rodenburg, R., Smit, K., Sukumaran, S. K., Wortmann, S. B., Averdunk, L., Munch, J., Ho, J. P., Kwok, A. M. K., Nieuwenhuis, E. E. S., van Hasselt, P. M., Schwartz, I. V. D., Lubout, C. M. A., Bosch, A. M., …, & Fuchs, S. A. (2026). Tailored Amino Acid Treatment for Pediatric Patients With Mitochondrial Aminoacyl‐ tRNA Synthetase Deficiencies. Journal of Inherited Metabolic Disease. https://doi.org/10.1002/jimd.70254

Vancouver

Muffels IJJ, Kok G, Tang Z, Medeiros LS, Poswar FO, Vermeij WP, et al. Tailored Amino Acid Treatment for Pediatric Patients With Mitochondrial Aminoacyl‐ tRNA Synthetase Deficiencies. Journal of Inherited Metabolic Disease. 2026. doi:10.1002/jimd.70254

BibTeX
@article{Muffels2026,
  author = {Muffels, I J J and Kok, G and Tang, Z and Medeiros, L S and Poswar, F O and Vermeij, W P and Rodenburg, R and Smit, K and Sukumaran, S K and Wortmann, S B and Averdunk, L and Munch, J and Ho, J Pak-Lam and Kwok, A M K and Nieuwenhuis, E E S and van Hasselt, P M and Schwartz, I V D and Lubout, C M A and Bosch, A M and Koop, K and van Konijnenburg, E M M Hoytema and Fuchs, S A},
  title = {Tailored Amino Acid Treatment for Pediatric Patients With Mitochondrial Aminoacyl‐ tRNA Synthetase Deficiencies},
  journal = {Journal of Inherited Metabolic Disease},
  year = {2026},
  doi = {10.1002/jimd.70254}
}
Kostenlos starten →